Datum & tid
16 nov 2021
Lägg till i kalender
For more than a year the world has battled with the COVID19 pandemic. Effective vaccine technologies have been developed at record speed, in many cases due to adoption of new ’gene delivery’ vaccine technologies eg. mRNA or adenoviruses. What do we know about these vaccines and how does this relate to Gene Therapies?
VA’s Cissi Askwall is one of the opening speakers at this free online conference on the topic:
“Acceptance and understanding of the public to vaccination against COVID19”
- Cissi Billgren Askwall – Secretary General, Vetenskap & Allmänhet
- Sarah Earnshaw Blomquist – Investigator, Folkhälsomyndigheten
- Matti Sällberg – Professor, Karolinska Institutet
- Andreas Heddini – AstraZeneca, LIF medical council
ATMP Sweden is a national network for activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Their goal is to promote collaboration and communication that is needed for accelerated and effective ATMP based patient solutions.